GLP-1 adherence drops past one key price
The monthly cost that pushes most GLP-1 patients off their prescriptions
Read ArticleThe monthly cost that pushes most GLP-1 patients off their prescriptions
Read Article
The monthly cost that pushes most GLP-1 patients off their prescriptions

Record earnings, a $50B buyback and a rate hike land at JPMorgan.

Apple’s single-bank launch barely scratches a UPI-dominated market

Analysts call the 16% slide an overreaction to the Bluevine deal.

NGX’s top executive took the UN floor with one loaded parallel

Six interlocking engines power Apple’s run toward a $5 trillion valuation.

MTN Nigeria barely budged while billions vanished from the market

Moniepoint is selling Dangote shares where you withdraw cash

Circle grants fund UN stablecoin payments as WFP slashes food aid










Markets, deals, policy
Budgeting, retirement, income
Stocks, funds, portfolios
Mortgages, debt, scores
Filing, deductions, accounts
Cash flow, capital, fintech
AI in finance, fintech, automation
Calculators, templates, guides
Newsletter
One email every Sunday. The week’s most useful guides, market-moving stories, and practical tools — chosen by our editors.